EDAP TMS SA (EDAP): Market Cap to Revenue

Symbol and logo of brand EDAP Medical (EDAP)

The current P/S valuation in the GURU.Markets terminal is illustrated by a chart where the value is fixed at 2.20. EDAP TMS S.A. generates profit based on the sale of Focal One robotic systems. Non-contact ultrasound therapy supports ESG standards by reducing hospital waste. The humanitarian profile of the products minimizes sanction risks, ensuring business stability within the global healthcare market.

EDAP EDAP Medical P/S Multiple (07/04/2022 - 06/01/2026)

Analytical breakdowns for EDAP TMS S.A. (EDAP)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:EDAP EDAP TMS SA
Core merchandise of EDAP TMS

The P/S multiple is calculated by dividing the market capitalization of EDAP TMS S.A. (EDAP) by its total annual revenue. This indicator determines the market value of one dollar of sales, reflecting the degree of business overvaluation or its stage of maturity. For a company with global demand for urological system consumables, this metric confirms the stability of cash flows. By analyzing the P/S multiple chart, an investor can assess the expansion rate of minimally invasive technologies.

Competitors of EDAP TMS S.A.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|Price to Sales STRATA Skin Sciences, Inc. (SSKN)|GCTK (GlucoTrack, Inc.) - P/S Multiple|Market Cap to Revenue Ratio NAOV (nanovibronix.com)|P/S Multiple VERO|P/S Multiple Nuwellis Corp (NUWE)|Price-to-Revenue Ratio Aethlon Medical AEMD|ASXC (Asensus Surgical Inc) - Price-to-Sales Ratio|AVGR: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio BSGM (BioSig)|CUTR (Cutera, Inc) - Market Cap to Revenue|KNW: Market Cap to Sales Volume|Price-to-Revenue Ratio Inari Medical, Inc.|Market Cap to Revenue nevro.com (NVRO)|Price-to-Revenue Ratio ReShape Lifesciences (RSLS)|Price-to-Revenue Coefficient Silk Road Medical, Inc.